CLAIM CARD
Mechanistically, the evidence relates to pathways of mitochondrial energy metabolism, antioxidant defense, and inflammation. The clinical RCT by Xu 2018 suggests CoQ10 may improve ovarian response and embryo quality, potentially through enhancing mitochondrial function in oocytes. Preclinical and human data from Alehagen 2019 and Alehagen 2023 indicate that selenium and CoQ10 intervention can alter metabolic profiles and age-related biomarkers, supporting a role in mitigating oxidative stress and inflammation. In exercise physiology, a clinical study found that ubiquinol supplementation at 200 mg affected hematological and inflammatory signaling (Diaz-Castro 2020). By contrast, the large meta-analytic findings on statins (Bielecka-Dabrowa 2019, Symvoulidis 2023) are more indirectly related, as they reflect outcomes in patients on HMG-CoA reductase inhibitors, which can deplete endogenous CoQ10 synthesis, creating a mechanistic rationale for considering CoQ10 status.
Evidence grade: exploratory
Contradiction status: none
Publication: b8dee5f7-0023-4af5-bacc-446de915555a
Provenance: Derivation Web chain
Citation Support
source_1Xu 2024source_2Spiegeleer 2025source_3Shang 2024source_4Alehagen 2020source_5Phan 2020